ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    An Integrative Approach for the Assessment of Peritubular Capillaritis Extent and Score in Microvascular Inflammation – Association with Transplant Glomerulopathy and Graft Loss

    N. Kozakowski,1 H. Herkner,2 F. Eskandary,3 M. Eder,3 W. Winnicki,3 G. Bond,3 Ž. Kikić.3

    1Department of Pathology, Medical University of Vienna, Vienna, Austria; 2Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria; 3Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

    Background:Banff Classification accepts two histomorphological features as surrogates of HLA Antibody-Antigen interaction on renal endothelium: C4d staining and microvascular inflammation scores (MVI sum score:ptc+g≥2) which…
  • 2018 American Transplant Congress

    The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis

    S. Wan,1,2 T. Ying,1,2 K. Wyburn,1,2 D. Roberts,3,4 M. Wyld,1,2 S. Chadban.1,2

    1Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia; 2Sydney Medical School, University of Sydney, Sydney, Australia; 3Department of Renal Medicine, Canberra Hospital and Health Services, Canberra, Australia; 4Medical School, Australian National University, Canberra, Australia.

    Introduction: Current treatment strategies for antibody-mediated rejection (AMR) in kidney transplantation are based on low quality data from a small number of controlled trials. Novel…
  • 2018 American Transplant Congress

    Decreased Clinical Significance of Isoagglutinin Titer with the Current Desensitization Protocol in ABO-Incompatible Kidney Transplantation

    C. Baek, H. Kim, W. Yang, D. Han, S-.K. Park.

    Department of Internal Medicine, Division of Nephrology, Asan Medical Center, Seoul, Republic of Korea; Department of Surgery, Asan Medical Center, Seoul, Republic of Korea.

    ABO-incompatible (ABOi) kidney transplantation (KT) has become a routine procedure with graft survival rates comparable to those of ABO-compatible KT. However, the clinical significance of…
  • 2018 American Transplant Congress

    Compatible Donor and Recipient Pairs' Perspectives on Participation in Kidney Paired Donation Programs: The Emotional Implications of Indirect Donation and Transplantation

    M. Fortin,1 J. Gill,2 F. Ballesteros,1 J. Gill.2

    1CHUM, Montreal, Canada; 2UBC, Vancouver, Canada.

    The inclusion of compatible pairs in kidney paired donation (KPD) may be a strategy to increase the chance of transplantation for incompatible pairs in KPD…
  • 2018 American Transplant Congress

    Cryptococcal Infections in Kidney Transplant Recipients. A Single Center Experience

    M. Radisic,1 N. Pujato,1 A. Dotta,2 R. Livia Franzini,2 M. Bravo,1 L. Rodriguez Rilo,1 C. Giampieri,2 L. Leon,1 M. Rial,1 D. Casadei.1

    1Infectious Diseases, Instituto de Nefrologia de Buenos Aires, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina; 2Kidney Transplantation, Instituto de Nefrologia de Buenos Aires, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina.

    Cryptococcal infections are infrequent but a cause of morbidity & mortality in transplant (T) recipients. Best treatment and the need for secondary prophylaxis are still…
  • 2018 American Transplant Congress

    Diabetic Nephropathy after Kidney Transplantation in Patients with Pre-Transplantation Type II Diabetes May Occur Later and Be Less Common Than Previously Thought

    A. Cimeno, J. Munley, S. Sultan, M. Weir, S. Bartlett, C. Drachenberg, A. Hararian, J. Bromberg, J. Scalea.

    Surgery, University of Maryland, Baltimore, MD.

    Background: Classical medical teaching suggests that diabetic nephropathy occurs more quickly in transplanted kidneys than in the native kidneys. The largest report of post-transplantation diabetic…
  • 2018 American Transplant Congress

    Hyperkalemia in the Early Post Renal Transplant Period

    E. Christie, J. Okel, M. Gowrishankar.

    Division of Nephrology, University of Alberta, Edmonton, AB, Canada; Division of Nephrology, University of Alberta, Edmonton, AB, Canada; Division of Pediatrics, University of Alberta, Edmonton, AB, Canada.

    Hyperkalemia is a recognized and potentially life threatening complication post renal transplantation. Aside from delayed graft function, the most frequent culprit identified is pharmacotherapy. Many…
  • 2018 American Transplant Congress

    Living Donor Renal Transplantation in Adult Renal Transplant Recipients Varies Markedly across UNOS Networks

    A. Brar,1 A. Gruessner,1 M. Salifu,1 R. Gruessner,2 N. Sumrani,2 D. John,2 F. Tedla.1

    1Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY; 2Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY.

    Background: Outcome after living donor kidney transplantation (LD) is significantly better than after deceased donor transplantation (DD). Disparities in access to living donor renal transplantation…
  • 2018 American Transplant Congress

    Post-Hoc Analysis of Everolimus Trough Levels around the Onset of Related Adverse Events and Treatment Discontinuation in De Novo Kidney Transplant Recipients from the US92 Study

    F. Shihab,1 Y. Qazi,1 V. Peddi,1 D. Shaffer,1 K. McCague,2 D. Patel,2 S. Mulgaonkar.1

    1US92 Study Group, Salt Lake City; 2Novartis Pharmaceutical Corporation, East Hanover.

    Purpose: Around 30%-50% of kidney transplant recipients (KTR) on sirolimus discontinue treatment due to drug-related adverse events (AE) and ~23% on everolimus (EVR) discontinue treatment…
  • 2018 American Transplant Congress

    Evanescent Antibodies: A Report on the Natural History of Anti-Blood Group A2 Antibodies and Their Rapid Resolution in Patients Awaiting A2 to B Transplantation

    S. Radomski, S. Rosen-Bronson, D. Li, M. Awwad, G. Vranic, B. Javaid, P. Abrams, S. Yi, M. Cooper, A. Gilbert.

    Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.

    Introduction: Despite the benefits of A2 to B transplants, centers have been reluctant to adopt such a program due to unanswered questions including whether elevation…
  • « Previous Page
  • 1
  • …
  • 317
  • 318
  • 319
  • 320
  • 321
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences